You have full text access to this Open Access content

Thoracic Cancer

Cover image for Vol. 8 Issue 3

Edited By: Qinghua Zhou and Yan Sun

Impact Factor: 1.116

ISI Journal Citation Reports © Ranking: 2016: 56/59 (Respiratory System); 202/217 (Oncology)

Online ISSN: 1759-7714

Recently Published Issues

See all


Read the NEW Virtual Issue on Thoracic Cancer Epidemiology in China FREE online

Virtual Issue

Thoracic cancers (lung cancer, breast cancer, esophageal cancer, etc.) are the most common cancers and the leading causes of cancer death in China. In this issue, the National Cancer Center of China released the epidemiological data on thoracic cancers in China, which could reflect the current status and trends of these cancers in China.



Thoracic Cancer has been selected to be indexed and included in MEDLINE/PubMed.

Open Access!

Thoracic Cancer will become an open access journal from January 2015. Manuscripts submitted after 25 November 2014 and accepted for publication will be published as open access articles, immediately free to read, download and share. Authors or their funder will be required to pay an Article Publication Charge upon acceptance.

The only English language and international lung cancer journal from Asia-Pacific!

Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, and other thoracic malignancies.

Call for Papers

Submit Online


Reach the world with your research

Average time for submission to first decision is just 18 days!

Review articles - Free Online


From “awake” to “monitored anesthesia care” thoracic surgery: A 15 year evolution

Human papillomavirus and non-small cell lung cancer

Role of new radiation techniques in the treatment of pleural mesothelioma

Molecular mechanisms of LKB1 induced cell cycle arrest

Diagnostic value of autofluorescence bronchoscopy in lung cancer

Management of malignant pleural effusion: Options and recommended approaches

Clinical and biologic prognostic factors in malignant pleural mesothelioma

EBUS and EUS guided fine needle aspirations for molecular diagnostic analysis in lung cancer

Proton therapy for non–small cell lung cancer: Current evidence and future directions

Proton therapy for lung cancer

Current concepts in the management of leakages after esophagectomy

Updates on endoscopic therapy of esophageal carcinoma

Endobronchial ultrasound (EBUS) with tranbronchial needle aspiration (TBNA) versus mediastinoscopy for mediastinal staging in non-small cell lung cancer (NSCLC) thoracic cancer

The role of endobronchial ultrasound in central early lung cancer

Mediastinal re-staging of non small-cell lung cancer

Radiotherapy dose calculation on KV cone-beam CT image for lung tumor using the CIRS calibration

Demonstration program of population-based lung cancer screening in China: Rationale and study design

Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer

Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage

Overview of fundamental study of pazopanib in cancer

Targeting the Notch signaling pathway in cancer therapeutics